Roger Y. Kim, MD, MSCE

Interventional Pulmonology
Accepting new patients
Harron Lung Center Perelman
Schedule onlineCall 215-615-5864
Headshot of Roger Y. Kim, MD, MSCE
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania

I am an Assistant Professor of Medicine at the University of Pennsylvania Perelman School of Medicine, a practicing interventional pulmonologist, and a physician-scientist. Clinically trained in internal medicine, pulmonary diseases, critical care medicine, and interventional pulmonology, I see patients at the Harron Lung Center Perelman and perform advanced diagnostic and therapeutic bronchoscopy and minimally invasive thoracic procedures at the Hospital of the University of Pennsylvania.

My National Cancer Institute (NCI)-funded research program focuses on the early detection of lung cancer and the optimization of the thoracic oncology diagnostic process. I am the Principal Investigator of the first investigator-initiated pragmatic randomized clinical trial assessing the effect of a pulmonary nodule risk stratification biomarker on medical decision-making (NCT05968898) and a member of the Population-based Research to Optimize the Screening Process (PROSPR) Lung Consortium, a NCI-funded multi-institutional research collaboration.

I received my undergraduate degree from Yale College and MD from the Yale University School of Medicine. I completed internal medicine residency at Yale-New Haven Hospital and pulmonary, critical care, and interventional pulmonology fellowships at the Hospital of the University of Pennsylvania. I also earned a Master of Science in Clinical Epidemiology (MSCE) degree from the University of Pennsylvania.

My education and training

  • Medical School: Yale University School of Medicine
  • Residency: Yale-New Haven Hospital
  • Fellowship: University of Pennsylvania Health System

Watch video featuring Roger Y. Kim, MD, MSCE on YouTube

Spoken languages

English
English

Reviews

Average Rating

60 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
very knowledgeable and takes time to explain all the details. very friendly easy to talk with. it was a successful visit.
Anonymous
April 2026
dr. kim's personal care and interest in my particular needs.
Anonymous
March 2026
we had a strong sense of trust and understanding in what he told us and how he explained things to us.
Anonymous
January 2026
i felt that i got thorough care from a highly qualified doctor.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Kim is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Ezenwankwo E, Nnate D, Kim RY, Eberth JM, Kim YW Reframing Computed Tomography-Associated Cancer Concerns in Lifesaving Screening: Keeping the Focus on Lives Saved , The Lancet Regional Health – Americas, 58: 2026,101451

Burnett-Hartman AN, Carroll NM, Wain KF, Hixon BP, Vachani A, Greenlee RT, Honda SA, Kim RY, Neslund-Dudas C, Oshiro CES, Rendle KA, Simoff M, Ritzwoller DP Lung Cancer Yield by Baseline Screening Lung-RADS Assignment and Patient Factors: The PROSPR-Lung Consortium , CHEST Pulmonary, 4(2): 2026,100243

Kim RY, Rings A, Pickup LC, Ibrahim O, Vachani A Theoretical Clinical Utility of Advanced Practice Provider Use of an Artificial Intelligence Radiomics-based Tool for Pulmonary Nodule Evaluation and Management , CHEST Pulmonary, 4(2): 2026,100242

Caruso CR, Kim RY Improving Lung Cancer Screening Diagnostic Efficiency , Current Opinion in Pulmonary Medicine , 32(4): 2026,261-269

Kim RY, Gupta A, Ang L, Bilger A, Vachani A, Rendle KA Clinicians’ Cancer Risk Assessment among Patients with Pulmonary Nodules: A Qualitative Study , Ann Am Thorac Soc, 23(3): 2026,458-463

Ritzwoller DP, Carroll NM, Wain KF, Hixon BP, Kim RY, Maiyani M, Steiner JS Examining Trends in Lung Cancer Screening over 10 Years: Eligibility, Participation, Cancer Detection, and Quality Implications , Cancer, 131(24): 2025,e70211

Caruso CR, Vachani A, Kim RY Monitoring the Harms of Lung Cancer Screening: Why the Non-Malignant Resection Rate Is Our Best Bet , Journal of the American College of Radiology, 22(12): 2025,1569-1571

Kim RY The Association of Lung Cancer Screening Centralization With Annual Adherence Rates , CHEST, 168(3): 2025,572-573

Caruso CR, Kim RY, Rendle KA, Vachani A Evaluating the Non-Malignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification , CHEST, 168(5): 2025,1271-1274

Kim RY, Rendle KA, Mitra N, Neslund-Dudas C, Greenlee RT, Honda SA, Schapira MM, Jeon J, Meza R, Ritzwoller DP, Vachani A Adherence to Annual Lung Cancer Screening and Rates of Cancer Diagnosis , JAMA Network Open, 8(3): 2025,e250942

View all publications